Back to Search
Start Over
Identification and pharmacological profile of SPP1, a potent, functionally selective and brain penetrant agonist at muscarinic M 1 receptors.
- Source :
-
British journal of pharmacology [Br J Pharmacol] 2019 Jan; Vol. 176 (1), pp. 110-126. Date of Electronic Publication: 2018 Nov 16. - Publication Year :
- 2019
-
Abstract
- Background and Purpose: We aimed to identify and develop novel, selective muscarinic M <subscript>1</subscript> receptor agonists as potential therapeutic agents for the symptomatic treatment of Alzheimer's disease.<br />Experimental Approach: We developed and utilized a novel M <subscript>1</subscript> receptor occupancy assay to drive a structure activity relationship in a relevant brain region while simultaneously tracking drug levels in plasma and brain to optimize for central penetration. Functional activity was tracked in relevant native in vitro assays allowing translational (rat-human) benchmarking of structure-activity relationship molecules to clinical comparators.<br />Key Results: Using this paradigm, we identified a series of M <subscript>1</subscript> receptor selective molecules displaying desirable in vitro and in vivo properties and optimized key features, such as central penetration while maintaining selectivity and a partial agonist profile. From these compounds, we selected spiropiperidine 1 (SPP1). In vitro, SPP1 is a potent, partial agonist of cortical and hippocampal M <subscript>1</subscript> receptors with activity conserved across species. SPP1 displays high functional selectivity for M <subscript>1</subscript> receptors over native M <subscript>2</subscript> and M <subscript>3</subscript> receptor anti-targets and over a panel of other targets. Assessment of central target engagement by receptor occupancy reveals SPP1 significantly and dose-dependently occupies rodent cortical M <subscript>1</subscript> receptors.<br />Conclusions and Implications: We report the discovery of SPP1, a novel, functionally selective, brain penetrant partial orthosteric agonist at M <subscript>1</subscript> receptors, identified by a novel receptor occupancy assay. SPP1 is amenable to in vitro and in vivo study and provides a valuable research tool to further probe the role of M <subscript>1</subscript> receptors in physiology and disease.<br /> (© 2018 The British Pharmacological Society.)
- Subjects :
- Animals
CHO Cells
Cells, Cultured
Cricetulus
Male
Mice
Mice, Inbred C57BL
Molecular Structure
Piperidines chemistry
Rats
Rats, Sprague-Dawley
Spiro Compounds chemistry
Structure-Activity Relationship
Xenopus
Osteopontin agonists
Piperidines pharmacology
Receptor, Muscarinic M1 agonists
Spiro Compounds pharmacology
Subjects
Details
- Language :
- English
- ISSN :
- 1476-5381
- Volume :
- 176
- Issue :
- 1
- Database :
- MEDLINE
- Journal :
- British journal of pharmacology
- Publication Type :
- Academic Journal
- Accession number :
- 30276808
- Full Text :
- https://doi.org/10.1111/bph.14510